Insulet Corporation <PODD.O>: Benchmark cuts target price to $185 from $250
PODD•Related News
Medtronic wins FDA breakthrough device tag for Sphere-9 ventricular arrhythmia catheter
MDT•
Evolent Q2 FY26 net loss narrows to $28.36 million; revenue rises 46.84% to $652.52 million
EVH•
Datadog Q2 revenue beats on large customer growth, AI adoption
DDOG•
Kenvue slips after slight quarterly miss
KVUE•
ConocoPhillips CEO Ryan Lance to retire
COP•